Attached files
| file | filename |
|---|---|
| EX-4.4 - WARRANT - TENAX THERAPEUTICS, INC. | tnx_ex44.htm |
| EX-4.3 - CERTIFICATE OF DESIGNATION - TENAX THERAPEUTICS, INC. | tnx_ex43.htm |
| S-1/A - S-1/A - TENAX THERAPEUTICS, INC. | tenx_s1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting
Firm
We
consent to the incorporation by reference in this Registration
Statement on Form S-1/A, as amended, of our report dated April 2,
2018, relating to the consolidated financial statements of Tenax
Therapeutics, Inc. (the “Company”), appearing in the
Annual Report on Form 10-K of the Company for the year ended
December 31, 2017, and to the reference to our firm under the
heading “Experts” in the prospectus.
/s/ CHERRY BEKAERT LLP
Raleigh,
North Carolina
December
3, 2018